VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (9466)	12/17/2002 6:07:18 PM
From: Biomaven	of 9719

From Bloomberg: 12/17 17:25 Corixa Has Shown Some Benefit From Cancer Drug, FDA Panel Says By Kerry Dooley, kdooley@bloomberg.net or cell 202-297-1120 Bethesda, Maryland, Dec. 17 (Bloomberg) -- Corixa Corp. has shown that its experimental Bexxar drug may help some people who were not cured by earlier treatment for a cancer of the immune system, a U.S. government panel said. A Food and Drug Administration advisory committee voted 10 to three on an agency question, seeking its view on how well Bexxar works. The FDA will use the panel's decision as it reviews Corixa's application for Bexxar approval. bloomberg.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next